WDR37 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the WDR37 protein, a member of the WD repeat-containing protein family. WDR37 is characterized by its WD40 repeat domains, which are highly conserved structural motifs that facilitate protein-protein interactions. These interactions are crucial for the assembly of multiprotein complexes that play roles in various cellular processes, including signal transduction, gene expression, and protein turnover. WDR37 is believed to participate in the regulation of cellular homeostasis and intracellular signaling by acting as a scaffold that organizes proteins into functional complexes. By inhibiting WDR37, these compounds disrupt its ability to facilitate these essential molecular interactions, which in turn can affect the proper functioning of cellular pathways dependent on its scaffolding role.
The mechanism of action for WDR37 inhibitors typically involves binding to the WD40 repeat domains or other critical regions of the protein, thereby blocking its interactions with other cellular proteins. This inhibition prevents WDR37 from assembling or stabilizing the multiprotein complexes that are vital for processes such as cell cycle regulation, chromatin remodeling, and intracellular trafficking. Researchers use WDR37 inhibitors to investigate the specific biological functions of this protein and its contributions to broader cellular networks. By selectively targeting WDR37, these inhibitors provide insights into how WD repeat-containing proteins influence cellular architecture and communication, offering valuable perspectives on how the disruption of protein-protein interactions can affect the maintenance of cellular balance and the coordination of essential molecular processes within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor that can affect the ubiquitin-proteasome system, potentially influencing WDR37-associated functions. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor; affects the ubiquitin-proteasome pathway which may indirectly affect WDR37-related processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor that can potentially modulate pathways that WDR37 is involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K; may influence pathways related to WDR37. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Protein synthesis inhibitor; can affect protein turnover and indirectly influence WDR37. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor; by influencing mTOR signaling, it could indirectly impact WDR37-associated functions. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor; can potentially influence signaling pathways related to WDR37. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor; may influence pathways associated with WDR37. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor; could indirectly modulate WDR37's function by affecting JNK signaling. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $204.00 $265.00 | 29 | |
Akt signaling modulator; might influence pathways WDR37 is associated with. | ||||||